首页|丹皮酚通过调控动脉粥样硬化中的miR-152-3p/ASPH轴抑制氧化低密度脂蛋白诱发的小鼠血管内皮细胞凋亡、炎症反应和氧化应激

丹皮酚通过调控动脉粥样硬化中的miR-152-3p/ASPH轴抑制氧化低密度脂蛋白诱发的小鼠血管内皮细胞凋亡、炎症反应和氧化应激

扫码查看
目的 揭示丹皮酚通过调控miR-152-3p/ASPH轴在ox-LDL诱导 的血管内皮细胞(vascular endothelial cells,VECs)进展中的作用。方法 首先,用不同浓度的氧化低密度脂蛋白(oxidized low-density lipoprotein,ox-LDL)(0、25、50、100 μg·mL-1)处理小鼠VECs,选取100 μg·mL-1 ox-LDL进行实验。然后,用不同浓度的丹皮酚(30、60、120 μmol·L-1)或辛伐他汀(30 μmol·L-1)处理VECs。接着,使用细胞计数试剂盒-8 和流式细胞术分别用于测定细胞活力和凋亡。此外,使用酶联免疫吸附法分析了IL-1β和IL-6 的水平,并使用相关试剂盒检测了活性氧、乳酸脱氢酶和丙二醛的含量。此外,通过qRT-PCR或Western blot检测miR-152-3p和天冬氨酰(天冬酰胺)β-羟化酶(aspartate-β-hydroxylase,ASPH)的表达。miR-152-3p和ASPH之间的相互作用由starBase预测,然后通过双荧光素酶报告基因实验和RNA结合蛋白免疫沉淀实验证实。结果 100 μg·mL-1 ox-LDL显著抑制VECs活力,并促进细胞凋亡、炎症反应和氧化损伤。而丹皮酚的处理以剂量依赖性的方式增加细胞活力,抑制ox-LDL诱导的细胞凋亡。丹皮酚以剂量依赖性的方式降低ox-LDL诱导的IL-1β和IL-6 的水平,以及以剂量依赖性的方式减弱ox-LDL对 ROS、MDA 和 LDH 含量的促进作用。另外,ox-LDL对miR-152-3p表达的抑制作用和对ASPH表达的促进作用也被丹皮酚逆转,且120 μmol·L-1丹皮酚效果最好。120 μmol·L-1丹皮酚能够上调miR-152-3p或下调ASPH,进一步促进丹皮酚对VECs生长的保护作用,miR-152-3p靶向负调控ASPH表达。结论 丹皮酚通过调节miR-152-3p/ASPH轴减弱ox-LDL对小鼠VECs生长的影响,为AS的治疗提供理论基础。
Paeonol inhibits ox-LDL-induced apoptosis,inflammation,and oxidative stress of mouse vascular endothelial cells by regulating the miR-152-3p/ASPH axis in atherosclerosis
Objective The study was to uncover the action of paeonol in the progression of ox-LDL-stimulated vascular endothelial cells(VECs)via modulating microRNA(miR)-152-3p/aspartate-β-hydroxylase(ASPH)axis.Methods First,mouse VECs were treated with different concentrations of ox-LDL(0,25,50,100 μg·mL-1),and 100 μg·mL-1 was selected for further experiments.Then,VECs were treated with different doses of paeonol(30,60,120 μmol·L-1)or simvastatin(30 μmol·L-1).Then,determination of cell viability and apoptosis was via adopting cell counting kit-8(CCK-8)and flow cytometry.Additionally,analysis of interleukin(IL)-1β and IL-6 was conducted,and test of reactive oxygen species(ROS),lactate dehydrogenase(LDH)and malondialdehyde(MDA)contents was via adopting relevant kits.Furthermore,examination of miR-152-3p and ASPH was performed.Forecast of the interaction of miR-152-3p with ASPH was via starBase with verification.Results Ox-LDL(100 μg·mL-1)significantly inhibited the viability of VECs and promoted apoptosis,inflammatory response and oxidative damage.Paeonol treatment increased cell viability and inhibited ox-LDL-induced apoptosis in a dose-dependent manner.Moreover,paeonol reduced the levels of IL-1β and IL-6 induced by ox-LDL in a dose-dependent manner,and attenuated the promoting effects of ox-LDL on ROS,MDA and LDH content.In addition,the inhibitory effect of ox-LDL on miR-152-3p expression and the promotion effect on ASPH expression were also reversed by paeonol,and paeonol(120 μmol·L-1)had the best effect.Therefore,paeonol(120 μmol·L-1)was selected for subsequent transfection experiments.Up-regulation of miR-152-3p or down-regulation of ASPH could further promote the protective effect of paeonol on the growth of VECs,and miR-152-3p targeted and negatively regulated ASPH expression.Conclusion Paeonol attenuates the impact of ox-LDL on the growth of VECs in mice via controlling miR-152-3p/ASPH axis,offering a theoretical basis for AS cure.

paeonoloxidized low-density lipoproteinmiR-152-3paspartate-β-hydroxylasevascular endothelial cellatherosclerosis

刘岩、张磊、安硕、史玉娟、秦素霞

展开 >

河南医学高等专科学校,河南 郑州 451191

河南省老干部康复医院,河南 郑州 450003

黔南民族医学高等专科学校,贵州 都匀 558000

丹皮酚 氧化低密度脂蛋白 miR-152-3p 天冬氨酰(天冬酰胺)β-羟化酶 血管内皮细胞 动脉粥样硬化

河南省科技厅科技发展计划项目河南省职业教育教学改革研究与实践项目

212400410181豫教[2024]05846

2024

沈阳药科大学学报
沈阳药科大学

沈阳药科大学学报

CSTPCD
影响因子:0.604
ISSN:1006-2858
年,卷(期):2024.41(9)